Gilead Sciences (NASDAQ:GILD) just reported results for the first quarter of 2024.
- Gilead Sciences reported earnings per share of -$1.32. This was above the analyst estimate for EPS of -$1.49.
- The company reported revenue of $6.69 billion.
- This was 5.46% better than the analyst estimate for revenue of $6.34 billion.